Elife Holdings Ltd

Elife Holdings Ltd exhibits a capital structure with a market price of 0.127 HKD and a market cap of 206,678,752.76 HKD, with a price-to-book ratio of 4.09 and a price-to-tangible-book ratio of 4.09. The company's liquidity position is characterized by a current ratio of 1.6, but it has a negative operating cash flow of -32,915,000 HKD and a free cash flow of -53,929,000 HKD, indicating cash outflows from operations. Profitability metrics show a return on equity of -1.9359 and a return on assets of -0.7372, both significantly below the industry median for Medical Equipment, Supplies & Distribution. The company's operating income is negative at -53,579,000 HKD, and net income is also negative at -97,838,000 HKD, indicating a loss-making position. The company's revenue is distributed across four segments, with the supply chain business being the primary contributor. However, the Daily Clearing, Anti-epidemic and Other Consumable Products Business and the Licensed Branded Consumer Goods Business also play significant roles. The Esmart Digital Services segment is a newer addition to the company's offerings. Growth trajectory is mixed, with the company reporting a revenue of 177,551,000 HKD in the latest period. Analyst estimates suggest a revenue of 213,795,000 HKD, indicating a potential growth of 20.5% in the next reporting period. However, the company's net income remains negative, and the operating cash flow is also negative, suggesting ongoing financial challenges. Risk factors include a medium liquidity risk, with a negative net cash position after subtracting total debt. The company has a low dilution risk, with no significant dilution potential in the near term. The risk assessment indicates that the company's financial position is vulnerable to liquidity constraints, and the negative operating cash flow is a red flag for investors. Recent events include the company's continued focus on expanding its supply chain business and digital services. The company has also been involved in the sales and marketing of daily cleaning and anti-epidemic products, which may be influenced by ongoing public health concerns. The company's recent financial performance, as reflected in its negative net income and operating cash flow, suggests that it is facing significant operational and financial challenges.